MedTrace Logo

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

NCT02200328 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2017-05-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test if metronidazole prophylaxis is effective in decreasing the incidence of hospital induced Clostridium Difficile diarrhea among patients at high risk for this infection.

Conditions

  • Clostridium Difficile Diarrhea

Interventions

DRUG

Metronidazole

Metronidazole tablets 500mg orally or IV , 3 times a day for a maximum of 14 days

DRUG

Placebo

Placebo(Corn starch pill) orally 3 times a day for a maximum of 14 days

Sponsors & Collaborators

  • Alison Schneider

    lead OTHER

Principal Investigators

  • Alison Schneider, M.D. · Cleveland Clinic Florida

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200328 on ClinicalTrials.gov